Today: 8 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

The FTSE 100 rose 0.7% to 10,212.91 by 1104 GMT, as risk appetite improved after President Trump eased tariff threats against European NATO allies. Senior shares jumped 8.3% on a profit outlook upgrade, while Beazley fell 1% after rejecting a Zurich Insurance bid. JD Sports reported a 1.8% drop in like-for-like sales and warned of muted growth ahead.
22 January 2026
····
Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal founder Deepinder Goyal will step down as CEO on Feb. 1, with Blinkit head Albinder Dhindsa taking over. Dr Reddy’s won approval to sell a generic Ozempic in India and plans to launch 12 million semaglutide pens in the first year. Waaree Energies more than doubled its profit, while HPCL and Bank of India also reported higher earnings for the quarter.
22 January 2026
··
India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
··
ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

Australia’s S&P/ASX 200 rose 0.8% to 8,849, snapping a three-day losing streak, as energy and banks advanced but miners fell 1.6%. Santos and South32 each gained about 5%, while Northern Star dropped 8.8% on weak results. The unemployment rate fell to 4.1% and jobs surged by 65,200, lifting rate hike bets. AUSTRAC ordered an external audit of Airwallex over anti-money laundering concerns.
22 January 2026
····
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed shares dropped 3.4% to $11.64 in premarket trading Thursday, following a 94.7% surge the previous session after its Lucid Diagnostics unit secured a U.S. Veterans Affairs contract for the EsoGuard test. Lucid shares fell 10.6% premarket. Investors are seeking details on test rollout and volumes. PAVmed recently completed a 1-for-30 reverse stock split to meet Nasdaq requirements.
22 January 2026
··
Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Indian shares rebounded Thursday, with the Nifty 50 up 0.53% and Sensex gaining 0.49%, after President Trump dropped tariff threats against Europe and Greenland. The rally lost steam as profit-taking and foreign selling weighed, with FIIs net selling ₹1,788 crore. Dr. Reddy’s rose 5.2% on strong earnings, while Eternal fell 2.7% amid quick-commerce sector pressure.
22 January 2026
··
Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft shares fell 33% after the company announced a major restructuring and canceled six games, cutting its 2026 net bookings forecast to 1.5 billion euros and projecting a 1 billion euro operating loss. The company withdrew guidance for fiscal 2026/27. Trading paused at 4.6 euros per share, valuing Ubisoft at 616 million euros. Investors await further details at a Feb. 12 update.
22 January 2026
·
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.
22 January 2026
···
FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

Rothschild Redburn downgraded FedEx to Neutral and raised its price target to $317, citing the planned freight spin-off. Argus and Wolfe Research lifted their FedEx price targets to $350 and $355, respectively, while maintaining positive ratings. FedEx shares closed at $306.95, about 3.7% below their 52-week high. The company aims to complete the FedEx Freight spin-off by June 1, 2026.
22 January 2026
·
Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley Rejects Zurich’s $10bn Takeover Bid as Lloyd’s Plan B Takes Shape

Beazley’s board rejected Zurich Insurance’s £8.4 billion all-cash bid at 1,280p per share, calling it a “material undervaluation.” Beazley shares dropped about 3% after the announcement. Zurich faces a UK deadline to confirm or withdraw its offer and is preparing a Lloyd’s syndicate as an alternative entry into the market. Beazley urged shareholders to wait for full-year results due March 4.
22 January 2026
·
1 … 172 173 174 175 176 … 584
Go toTop